Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy
Marit J van Elsas(Leiden University Medical Center), Sjoerd H. van der Burg(Leiden University Medical Center)
Cited by 133
Related Papers
Therapeutic cancer vaccines
|Journal of Clinical Investigation|2015|1.1k
Human Papillomavirus (HPV) Upregulates the Cellular Deubiquitinase UCHL1 to Suppress the Keratinocyte's Innate Immune Response
|PLoS Pathogens|2013|178
The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma
|Oncotarget|2015|105
The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation
|Nature Communications|2015|79
Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy
|Journal for ImmunoTherapy of Cancer|2023|35